The Senate committee on health, education, labor and pensions (HELP) has rejected President Trump's nominee to lead the National Science Foundation (NSF), Jim O'Neill, after chairman Bill Cassidy (R-LA) said O'Neill "did not do enough to stand up for science" in his previous role. The decision effectively ends O'Neill's bid to head the embattled independent federal agency, which has faced major budget cuts and grant freezes under the current administration.
Why the Senate Committee Rejected Jim O'Neill
Cassidy's announcement came hours before O'Neill was scheduled to appear for his confirmation hearing on Wednesday. In opening remarks, Cassidy cited O'Neill's tenure as acting director of the Centers for Disease Control and Prevention (CDC) from August 2025 to February 2026, where he allegedly failed to push back against "irresponsible decisions and statements from Secretary Kennedy."
Cassidy also pointed to O'Neill's role in the firing of Susan Monarez, which raised "further concerns about the independent judgment he would bring to NSF." Several committee members shared those concerns, according to Cassidy, who added that while he likes O'Neill personally, "this time requires leadership and fortitude in standing up for what is right."
The Stakes for the National Science Foundation
The NSF is an independent federal agency that funds research across all scientific disciplines. Under the Trump administration, it has seen significant budget reductions and freezes on grants, raising alarms among scientists and policymakers about the future of U.S. research leadership.
O'Neill's rejection leaves the agency without a confirmed director at a critical juncture. The next nominee will face a Democratic-led Senate, which could complicate confirmation further. The White House has not yet indicated whom it will nominate next.
O'Neill's Record at HHS and CDC
Before his CDC role, O'Neill served as deputy secretary of the Department of Health and Human Services (HHS) from June 2025 to February 2026. During that time, he was involved in key decisions that drew scrutiny from lawmakers. His tenure at HHS overlapped with controversial statements and actions by Secretary Robert F. Kennedy Jr., which Cassidy referenced in his remarks.
The HELP Committee's decision reflects broader concerns about scientific integrity and the independence of federal agencies. O'Neill's failure to secure the nomination underscores the political challenges facing nominees who are perceived as insufficiently protective of science.
What This Means for Federal Science Policy
The rejection of O'Neill signals that Senate Republicans are willing to break with the White House on nominees they deem unqualified or insufficiently independent. It also highlights the increasing politicization of science funding and leadership.
With the NSF already reeling from budget cuts, the absence of a confirmed director could further destabilize the agency. Research institutions and universities that rely on NSF grants may face continued uncertainty. The next nominee will need to navigate a divided Senate and demonstrate a commitment to scientific integrity.
- Senate HELP Committee rejected Jim O'Neill's NSF nomination over concerns about his defense of science.
- O'Neill's CDC tenure and role in Susan Monarez's firing raised red flags for lawmakers.
- The NSF faces budget cuts and grant freezes, and now lacks a confirmed director.
- The next nominee will face a Democratic-led Senate, complicating confirmation.
- The decision underscores growing political tensions over federal science leadership.
Comparison of O'Neill's Roles and Committee Concerns
| Position | Tenure | Key Concerns Raised |
|---|---|---|
| Acting Director, CDC | Aug 2025 – Feb 2026 | Failed to push back against Secretary Kennedy's statements; role in firing Susan Monarez |
| Deputy Secretary, HHS | Jun 2025 – Feb 2026 | Involvement in controversial HHS decisions |
| NSF Director Nominee | Not confirmed | Lack of independent judgment; insufficient advocacy for science |
FAQ
Why was Jim O'Neill's nomination rejected?
Senate HELP Committee Chairman Bill Cassidy said O'Neill did not do enough to stand up for science during his time at the CDC and HHS, citing his failure to counter Secretary Kennedy's statements and his role in firing Susan Monarez.
What happens next for the NSF?
The White House must nominate a new candidate, who will face a Democratic-led Senate. The NSF continues to operate without a confirmed director amid budget cuts and grant freezes.
How does this affect federal science funding?
The lack of leadership at NSF could exacerbate uncertainty for research institutions relying on grants. The rejection signals potential resistance to nominees seen as insufficiently independent, which may influence future science policy.
What was O'Neill's role at the CDC?
O'Neill served as acting director of the CDC from August 2025 to February 2026. During that time, he was criticized for not pushing back against what Cassidy called irresponsible decisions and statements from Secretary Kennedy.
The rejection of O'Neill is part of a broader pattern of Senate scrutiny over Trump's nominees. Similar concerns have arisen over other picks, such as the Senate committee advancing Jay Clayton's nomination for DNI, where lawmakers weighed qualifications and independence. These battles highlight the high stakes of confirming leaders for critical agencies.
Meanwhile, the administration's focus on loyalty has also shaped other nomination fights. The Jay Clayton nomination advancing in Senate committee vote showed a smoother path, but O'Neill's case demonstrates that not all nominees clear the bar. The difference often lies in perceived independence and willingness to defend agency missions.
In another sign of political turbulence, Trump recently vowed a $1.8 billion fund as the Senate reconsiders its AG nominee. That story, covered in Trump vows $1.8B fund as Senate reconsiders AG nominee, illustrates how financial and political maneuvers intersect with confirmation processes. Such dynamics could influence how the White House approaches the next NSF pick.
The Senate HELP Committee's decision also comes amid delays in other high-profile confirmations. For instance, the Senate committee delaying Todd Blanche's attorney general vote reflects a cautious approach to vetting nominees. This pattern suggests that lawmakers are increasingly willing to press nominees on past actions and statements.
As the NSF seeks new leadership, the administration may look to nominees with stronger scientific credentials and a track record of independence. The Jay Clayton nomination advancing in Senate Intelligence Committee offers a contrast in how some nominees manage to navigate committee scrutiny. For O'Neill, the lack of such navigation proved fatal to his chances.
Ultimately, the rejection of O'Neill underscores the importance of standing up for scientific integrity in an era of political pressure. As the Trump committee moves to investigate Fed Governor Lisa Cook, it's clear that oversight and independence remain central themes in Washington. The next NSF nominee will need to demonstrate both.